Skip to content
Fencer Intel
medium 5.4

CVE-2019-25743 json

WordPress Soliloquy Lite 2.5.6 Persistent Cross-Site Scripting

published 5mo ago modified last mo. also EUVD-2019-20179

cvss
5.4
version 3.1, CNA
cisa kev
Not listed
not in CISA's catalog
epss
0.2%
EPSS 0.2% chance of exploitation in 30 days, percentile 6%
public exploits
0
none known

Summary

WordPress Soliloquy Lite 2.5.6 contains a persistent cross-site scripting vulnerability that allows authenticated attackers to inject malicious scripts by inserting script tags in the post title field. Attackers can submit POST requests to the post editing endpoint with script payloads in the post_title parameter, which are stored and executed when users preview the post.

Is CVE-2019-25743 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.

Check with Fencer

CISA SSVC

Exploitation
Proof of concept is public
Automatable
no
Technical impact
partial
Assessed
5mo ago

Exploit prediction

0.17% chance of exploitation in the next 30 days, higher than 6% of all scored CVEs (FIRST EPSS, 2026-11-09).

Exploits and checks

  • exploit-db.com https://www.exploit-db.com/exploits/47517 referenced PoC, tagged "exploit" by a source, unverified

CVSS scores

assigned by version score vector
CNA 4.0 5.1 CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:L/SI:L/SA:N
CNA 3.1 5.4 CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
CNA 4.0 5.1 CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Affected products

  • Soliloquywp Soliloquy Lite

Classification

Weakness
  • CWE-79 Improper Neutralization of Input During Web Page Generation
Technology feeds

References

Sources

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.